Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Ming-Biao Yin"'
Autor:
Farukh A. Durrani, Karoly Toth, Tanjima R. Zinia, Sylvia B. Smith, Ming Biao Yin, Youcef M. Rustum, Shousong Cao, Sreenivasulu Chintala, Arup Bhattacharya, Rebecca Dean, M. Shamsul Ola, Harry K. Slocum
Publikováno v:
Chemotherapy. 56:223-233
Background: The purpose of this study was: (1) to document the critical requirement of cystine for growth of human tumor cells in vitro, and (2) to determine the effect of the anticancer agent irinotecan on the cystine transporter xc– in head and n
Autor:
Ming-Biao Yin, Gunnar Hapke, Rami G. Azrak, Karoly Toth, Arup Bhattacharya, Cheryl Frank, Li Zr, Farukh A. Durrani, Shousong Cao, Y. M. Rustum
Publikováno v:
Oncogene. 25:2509-2519
Until recently, the use of Se-methylselenocysteine (MSC) as selective modulator of the antitumor activity and selectivity of anticancer drugs including irinotecan, a topoisomerase I poison, had not been evaluated. Therapeutic synergy between MSC and
Autor:
Rami G. Azrak, Youcef M. Rustum, Farukh A. Durrani, Zhan-Rong Li, Ming-Biao Yin, Cheryl Frank, Shousong Cao
Publikováno v:
Molecular Pharmacology. 66:153-160
Methylselenocysteine (MSC) is an organic selenium compound in preventative clinical trials involving prostate, lung, and colon carcinoma. We found that methioninase-activated MSC potentiates 7-ethyl-10-hydroxycamptothecin (SN-38)-induced cell lethali
Autor:
Ming-Biao Yin, Carol Wrzosek, Rami G. Azrak, Cheryl Frank, Gunnar Hapke, Youcef M. Rustum, Jiaxi Wu
Publikováno v:
Biochemical and Biophysical Research Communications. 295:435-444
A novel karenitecin, BNP1350, is a topoisomerase I-targeting anticancer agent with significant antitumor activity in vitro and in vivo. A BNP1350-resistant human head and neck carcinoma A253 cell line, denoted A253/BNPR, was developed. The A253/BNPR
Publikováno v:
Oncogene. 20:5249-5257
Promotion of apoptosis may potentiate the sensitivity of tumor cells to chemotherapeutic agents, thus improving the efficacy of cancer treatment. The transfection of the proapoptotic bax gene, which results in the overexpression of bax protein, augme
Publikováno v:
Cancer and Metastasis Reviews. 20:109-115
The common clinical problem in the successful treatment of cancer is the resistance of cancer cells to chemotherapeutic drugs. Chemotherapy kills drug-sensitive cells, but leaves behind a higher proportion of drug-resistant cells. The resistance can
Autor:
Hans Minderman, Carol Wrzosek, Youcef M. Rustum, Cheryl Frank, Rami G. Azrak, Udo Vanhoefer, Harry K. Slocum, Bin Guo, Ming-Biao Yin
Publikováno v:
Molecular Pharmacology. 57:453-459
Cellular topoisomerase I is an important target in cancer chemotherapy. A novel karenitecin, BNP1350, is a topoisomerase I-targeting anticancer agent with significant antitumor activity against human head and neck carcinoma A253 cells in vitro. As a
Autor:
Karoly Toth, Ming-Biao Yin, Bin Guo, Harry K. Slocum, Youcef M. Rustum, Shousong Cao, Cheryl Frank
Publikováno v:
International Journal of Cancer. 83:341-348
Time-dependent ladder-type DNA fragmentation and morphological alterations consistent with apoptosis were observed among A253 human head and neck squamous cell carcinoma (HNSCC) cells in nude mice from 15 to 18 days after transplantation, without any
Autor:
Cheryl Frank, Wieland Voigt, Ming-Biao Yin, Bin Guo, John F. Gibbs, Youcef M. Rustum, Udo Vanhoefer, Carol Wrzosek, Basil S. Skenderis
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1401(3):265-276
The newly synthesized calcium channel blocker, Ro44-5912, significantly potentiates doxorubicin (Dox)-induced cytotoxicity at non-cytotoxic concentrations in Dox-resistant human ovarian cell line, A2780/DX5, overexpressing P170-glycoprotein (Pgp). In
Autor:
Sanja Pajovic, Wieland Voigt, Jane Clifford Azizkhan, Cheryl Frank, Ming-Biao Yin, Youcef M. Rustum, Angeles Panadero, Udo Vanhoefer
Publikováno v:
Molecular Pharmacology. 51:630-636
In a previous study, we found that treatment of HCT-8 cells with ZD1694, a specific antifolate-based thymidylate synthase inhibitor, resulted in DNA fragmentation. In this study, we have demonstrated the dose- and time-dependent induction of DNA frag